Ethics and Public Policy Center
About EPPC Contact EPPC Support EPPC My EPPC
  Find:    
Home News & Updates Conferences & Events Programs Publications Fellows & Scholars

Home  >  Programs  > 
Bioethics and American Democracy
Home
Contact
News & Updates
Conferences
Publications
Books
Center Conversations
Event Transcripts
Browse by:
- Author
- Title
- Type
- Date
Scholars & Staff
 
 
 
 
 
 
 
Home  >  Publications  > 
IV. Commodifying Human Life
Posted: Wednesday, February 1, 2006


BIOETHICS AGENDA


The Law:

  • A prohibition on the buying, selling, and patenting of human organisms at any stage of development.

Why We Need Legislative Action:

  • Scientists who are eager to create and exploit human embryos and human fetuses as research tools or sources of spare parts also seek to patent and profit from their “inventions.”
     
  • On December 30, 2004, a leading researcher from the University of Pittsburgh applied for a patent on the process and product of human cloning. In other words: he wants to create cloned human embryos and own the rights to cloned human persons.
     
  • At present, the Weldon Patent Amendment prohibits the use of federal dollars for patents on human embryos, human fetuses, or human beings at any stage of development. But this amendment is not a permanent law but an annual part of the appropriations bill. And it does not prohibit the buying and selling of human embryos.

What the Law Does:

  • It establishes a clear moral principle: No human life should be created, used, and exploited as a commodity. Human beings are not laboratory inventions or things for our use.
     
  • It shuts down the economic incentives and private market for creating human embryo farms.
     
  • It prevents the slippery slope from embryo destruction to mass fetal farming.
     
  • It makes the Weldon amendment permanent.

What the Law Does Not Do:

  • The law does not affect past, present, future, or existing patents on embryonic or non-embryonic human stem cell lines.
     
  • It does not affect past, present, future, or existing patents on genes, cells, organs, animals, plants, or other combinations of living matter that are not human organisms.
     
  • It does not affect commerce, incentives, profit-making, or technology transfer that involves embryonic or non-embryonic human stem cell lines, animal stem cells, animal clones, genes, cells, or organs.




Related Links
Bioethics Agenda 2006
The New Atlantis (Winter 2008)
The New Atlantis
A Journal of Technology and Society

The New Atlantis is an effort to clarify the nation's moral and political understanding of all areas of technology, with a special emphasis on bioethics. The quarterly journal is an attempt to make sense of the larger questions surrounding technology and human nature, and the practical questions of governing and regulating science -- especially where the moral stakes are high and the political divides are deep.

In the latest issue:

The Editors on John McCain and the Stem Cell Debate.
Yuval Levin on the past and future of the “party of science.”
O. Carter Snead on brain scans and the conflicted aspirations of neuroscience.
Matthew B. Crawford on the dangers of a mindless brain science.
Cheryl Miller on the lively and fractious community of “infertiles.”
Thomas W. Merrill reads Descartes’ Discourse on Method.
Jeremy Lott on suburbs, bomb shelters, and bottled water.
Christy Hall Robinson on celebrity patients as advocates.
James C. Capretta on why health care records are so low-tech.
Caitrin Nicol on predictions of robotic intimacy.
David Franz on the utopian origins of Dilbert's sorkspace.
George Mitchell on drugs in baseball.

       ... and much more!

For more information:

Read old articles in our archive.  
Click here to subscribe.  
Visit www.TheNewAtlantis.com today! 


 The views expressed by EPPC scholars in their work are their individual views only and are not to be imputed to EPPC as an institution.     
© 1974 - 2008 Ethics and Public Policy Center
      Comments on the website or technical problems? E-mail webmaster@eppc.org